Amy Ronneberg has served as a director of Actuate Therapeutics since August 2024. She has been Chief Executive Officer of NMDP (formerly Be The Match), a nonprofit that facilitates bone-marrow transplantation, since March 2020, having previously served as its Chief Financial Officer from 2013 to 2020 and as President of NMDP BioTherapies, LLC. Earlier she held roles at Capella Education Company, including Chief Accounting Officer and Vice President of Operations, and was an Audit Manager at Ernst & Young. She serves as a director and finance committee chair of Allina Health and previously served on the board of Magenta Therapeutics, Inc. from 2018 to 2023. Ms. Ronneberg earned an M.B.A. from Capella University, a Corporate Directorship Certificate from Harvard Business School, and a B.B.A. in Accounting from the University of Wisconsin-Eau Claire.